Treatment of RA with Retinoic acid-platinum (II) Complex (RT-Pt (II)) can act by targeting the NF-κB pathway to inhibit the mRNA and protein expression of iNOS in RA models in rats. This evidence concerns the gene NOS2 and rheumatoid arthritis.